The Oxidative stress and its role in insulin resistance in polycystic ovary syndrome
DOI:
https://doi.org/10.63053/ijhes.5Abstract
The production of reactive oxygen species (ROS) can alter macromolecules in living organisms and can result in a wide range of injuries. Recently, oxidative stress has been known as a key mechanism in insulin resistance. Today, oxidative stress (OS) status assessment is performed using circulating markers such as malondialdehyde (MDA), superoxide dismutase (SOD) and glutathione peroxidase (GPX). Polycystic ovary syndrome (PCOS) with a prevalence of 4-12 % is the most common endocrine-metabolic disorder in the reproductive age of women. PCOS is now recognized as an important metabolic disorder. Insulin resistance (IR) independent of obesity in PCO women has been identified as a predisposing factor for type2 diabetes and cardiovascular disease (CVD). Oxidative stress index is strongly associated with PCOS. The role of oxidative stress is very important but not considered but it plays an important role in the development of IR. In this mini review, we presented a viewpoint about the key role of brain̕s IR/OS in the brain-ovarian axis in the women with PCOS. These review articles helps us to better understanding of the PCO etiology.
References
Moran LJ, Hutchison SK, Norman RJ, Teede HJ. Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2011; 162:CD007506.
Tehrani FR, Simbar M, Tohidi M, Hosseinpanah F, Azizi F. The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study. Reprod Biol Endocrinol. 2011;9:39.
Melo AS, Vieira CS, Barbieri MA, Rosa-E-Silva AC, Silva AA, Cardoso VC, et al. High prevalence of polycystic ovary syndrome in women born small for gestational age. Hum Reprod. 2010; 25: 2124–31.
Moran LJ, Misso ML, Wild RA, Norman RJ. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Human Reproduction Update. 2010; 16: 347-363.
Chereau A. Mémoires pour Servir à l'Étude des Maladies des Ovaires. Paris, France: Fortin, Masson; 1844.
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) Human Reproduction. 2004; 19: 41-47.
Peipei Jin & Yongyong Xie. Treatment strategies for women with polycystic ovary syndrome. Gynecol Endocrinol. 2017; 31:1-6.
Alchami A, O'Donovan O, Davies M. PCOS: diagnosis and management of related infertility. Obstetrics, Gynecology & Reproductive Medicine. 2015; 25: 279-282.
Pisoschi AM, Pop A. The role of antioxidants in the chemistry of oxidative stress: a review. European Journal of Medicinal Chemistry. 2015; 97: 55-74.
Cadenas E. Biochemistry of oxygen toxicity. Ann Rev Biochem. 1989; 58: 79-110.
Sharlip ID, Jarow JP, Belker AM, Lipshultz LI, Sigman M, Thomas AJ, et al. Best practice policies for male infertility. Fertility and sterility. 2002;77: 873.
Agarwal A, Gupta S, Sekhon L, Shah R. Redox considerations in female reproductive function and assisted reproduction: From molecular mechanisms to health implications. Antioxid Redox Signal. 2008; 10: 1375-403.
Riley PA. Free radicals in biology: oxidative stress and effects of ionizing radiation. Int J Rad Biol. 1994; 65: 27-33.
Cadenas E, Davies KJA. Mitochondrial free radical generation, oxidative stress, and aging. Free Rad Biol Med. 2000; 29: 222-30.
Koliaki C, Roden M. Alterations of mitochondrial function and insulin sensitivity in human obesity and diabetes mellitus. Annu. Rev. Nutr. 2016;36:337–367.
Martin S.D., McGee S.L. The role of mitochondria in the aetiology of insulin resistance and type 2 diabetes. Biochim. Biophys. Acta Gen. Subj. 2014; 1840: 1303–1312.
Ott M, Gogvadze V, Orrenius S, Zhivotovsky B. Mitochondria, oxidative stress and cell death. Apoptosis. 2007; 12:913-22.
Zuo L, Prather ER, Stetskiv M, Garrison DE, Meade JR, Peace TI, Zhou T. Inflammaging and oxidative stress in human diseases: from molecular mechanisms to novel treatments. Int J Mol Sci. 2019; 20:4472.
Angajala A, Lim S, Phillips JB, Kim JH, Yates C,You Z, Tan M. Diverse Roles of Mitochondria in Immune Responses: Novel Insights Into Immuno-Metabolism. Front Immunol. 2018; 9:1605.
Cronkite DA, Strutt TM. The Regulation of Inflammation by Innate and Adaptive Lymphocytes. J Immunol Res. 2018 Jun 11; 2018:1467538.
Siti HN, Kamisah Y, Kamsiah J. The role of oxidative stress, antioxidants and vascular inflammation in cardiovascular disease (a review). Vascular Pharmacology. 2015; 71: 40–56.
Haas MJ, Jurado-Flores M, Hammoud R, Feng V, Gonzales K, Onstead-Haas LD, Mooradian A. Inhibition of Pro-Inflammatory Cytokine Secretion by Select Antioxidants in Human Coronary Artery Endothelial Cells. Int J Vitam Nutr Res. 2020; 90:103-112.
Tan BL, Norhaizan ME, Liew WP, Sulaiman Rahman H. Antioxidant and oxidative stress: A mutual interplay in age-related diseases. Front Pharmacol. 2018; 9:1162.
Huang HY, Helzlsouer KJ, Appel LJ. The effects of vitamin C and vitamin E on oxidative DNA damage: results from a randomized controlled trial. Cancer Epidemiol Biomarkers Prev. 2000; 9: 647-52.
Pizzino G, Irrera N, Cucinotta M, Cucinotta M, Pallioet G. Oxidative Stress: Harms and Benefits for Human Health. Oxid Med Cell Longev. 2017; 2017:8416763.
Ilie IR. Advances in PCOS pathogenesis and progression-mitochondrial mutations and dysfunction. Adv Clin Chem. 2018; 86: 127-155.
Siti HN, Kamisah Y, Kamsiah J. The role of oxidative stress, antioxidants and vascular inflammation in cardiovascular disease (a review). Vascular Pharmacology. 2015; 71: 40–56.
Tiwari BK, Pandey KB, Abidi AB, Rizvi1 SA. Markers of Oxidative Stress during Diabetes Mellitus. Journal of Biomarkers. 2013; 2013: Article ID 378790, 8 pages.
Salim s. Oxidative Stress and Psychological Disorders. Curr Neuropharmacol. 2014; 12: 140-147.
Sosaa V, Molinéa T, Somozaa R, Paciuccib R, LLeonarta ME. Oxidative stress and cancer: An overview. Ageing Research Reviews. 2014; 12: 376-390.
Papalou O, Victor VM, Diamanti-Kandarakis E. Oxidative Stress in Polycystic Ovary Syndrome. Curr Pharm Des. 2016; 22:2709-22.
Tönnies E, Trushina E. Oxidative Stress, Synaptic Dysfunction, and Alzheimer's Disease. J Alzheimers Dis. 2017; 57:1105–1121.
Ohl K, Tenbrock K, Kipp M. Oxidative stress in multiple sclerosis: Central and peripheral mode of action. Exp Neurol. 2016; 277:58-67.
Abuelo A, Hernández J, Benedito JL, Castillo C. Oxidative stress index (OSi) as a new tool to assess redox status in dairy cattle during the transition period. Animal. 2013; 7: 1374-8
Sánchez-Rodríguez MA, Mendoza-Núñez VM. Oxidative Stress Indexes for Diagnosis of Health or Disease in Humans. Oxidative Medicine and Cellular Longevity. 2019; Article ID 4128152: 32 pages.
Mohamadin AM, Habib FA, Elahi TF. Serum paraoxonase 1 activity and oxidant/antioxidant status in Saudi women with polycystic ovary syndrome. Pathophysiology. 2010; 17: 189–196.
Sak S , Uyanikoglu H , Incebiyik A , Incebiyik H , Hilali NG , Sabuncu T , Sak E. Associations of serum fetuin-A and oxidative stress parameters with polycystic ovary syndrome. Clin Exp Reprod Med. 2018; 45:116-121.
Deepika M. L. N., Nalini S., Maruthi G., et al. Analysis of oxidative stress status through MN test and serum MDA levels in PCOS women. Pakistan Journal of Biological Sciences. 2014; 17: 574–577.
Seleem A. K., El Refaeey A. A., Shaalan D., Sherbiny Y., Badawy A. Superoxide dismutase in polycystic ovary syndrome patients undergoing intracytoplasmic sperm injection. Journal of Assisted Reproduction and Genetics. 2014; 31: 499–504.
Baskol G, Aygen E, Erdem F, Caniklioğlu A, Narin F, Sahin Y, Kaya T. Assessment of paraoxonase 1, xanthine oxidase and glutathione peroxidase activities, nitric oxide and thiol levels in women with polycystic ovary syndrome. Acta Obstetricia Gynecologica Scandinavica. 2012; 91: 326–330.
Savic-Radojevic A, Bozic Antic I, Coric V, Bjekic-Macut J, Radic T, Zarkovic M, Djukic T, Pljesa-Ercegovac M, Panidis D, Katsikis I, Simic T, Macut D. Effect of hyperglycemia and hyperinsulinemia on glutathione peroxidase activity in non-obese women with polycystic ovary syndrome. Hormone. 2015; 14: 101-108.
Sova H., Morin-Papunen L., Puistola U., Karihtala P. Distinctively low levels of serum 8-hydroxydeoxyguanosine in women with polycystic ovary syndrome. Fertility and Sterility. 2010; 94: 2670–2673.
Liu J, Zhang D. The role of oxidative stress in the pathogenesis of polycystic ovary syndrome. Sichuan Da Xue Xue Bao Yi Xue Ban. 2012; 43: 187–190.
Nasiri N, Moini A, Eftekhari-Yazdi P, Salman-Yazdi R, Zolfaghari Z, Arabipoor A. Abdominal obesity can induce both systemic and follicular fluid oxidative stress independent from polycystic ovary syndrome. European Journal of Obstetrics Gynecology and Reproductive Biology. 2015; 184: 112-116.
Savic-Radojevic A, Bozic Antic I, Coric V, Bjekic-Macut J, Radic T, Zarkovic M, Djukic T, Pljesa-Ercegovac M, Panidis D, Katsikis I, Simic T, Macut D. Effect of hyperglycemia and hyperinsulinemia on glutathione peroxidase activity in non-obese women with polycystic ovary syndrome. Hormone. 2015; 14: 101-108.
González F, Sreekumaran Nair K, Daniels JK, Basal E, Schimke JM. Hyperandrogenism sensitizes mononuclear cells to promote glucose-induced inflammation in lean reproductive-age women. American Journal of Physiology—Endocrinology and Metabolism. 2012; 302: E297-E306.
Federico A, Morgillo F, Tuccillo C, Ciardiello F., Loguercio C. Chronic inflammation and oxidative stress in human carcinogenesis. International Journal of Cancer. 2007; 121: 2381-2386.
Das S, Chattopadhyay R, Ghosh S, Ghosh S, Goswami SK, Chakravarty BN, Chaudhury K. Reactive oxygen species level in follicular fluid--embryo quality marker in IVF? Hum Reprod. 2006; 21:2403-7.
Zuo T, Zhu M, Xu W. Roles of Oxidative Stress in Polycystic Ovary Syndrome and Cancers. Oxid Med Cell Longev. 2016; 2016: 8589318.
Sak S, Uyanikoglu H, Incebiyik A, Incebiyik H, Hilali NG, Sabuncu T, Sak E. Associations of serum fetuin-Aand oxidative stress parameters with polycystic ovary syndrome. Clin Exp Reprod Med. 2018 Sep; 45(3): 116–121.
Zhang J, Bao Y, Zhou X, Zheng L. Polycystic ovary syndrome and mitochondrial dysfunction. Reprod Biol Endocrinol. 2019; 17: 67-82.
Lansdown A, Rees DA. The sympathetic nervous system in polycystic ovary syndrome: a novel therapeutic target? Clin Endocrinol (Oxf). 2012; 77: 791-801.
Cruz G, Fernandois D, Paredes AH.Ovarian function and reproductive senescence in the rat: role of ovarian sympathetic innervation. Reproduction. 2017; 153: R59–R68.
Rosenfield RL, Ehrmann DA. The pathogenesis of polycystic ovary syndrome (PCOS): The hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr Rev. 2016; 37: 467–520.
Dissen GA, Garcia-Ruda C, Paredes A, Mayer C, Mayerhofer A, Ojeda SR. Excessive ovarian production of nerve growth factor facilitates development of cystic ovarian morphology in mice and is a feature of polycystic ovarian syndrome in humans. Endocrinology. 2009; 150: 2906-2914.
Zangeneh FZ, Bagheri M, Naghizadeh MM. Hyponeurotrophinemia in Serum of Women with polycystic ovary syndrome as a low grade chronic inflammation. Open Journal of Obstetrics and Gynecology. 2015; 5: 459-469.
Kishi T. Regulation of the sympathetic nervous system by nitric oxide and oxidative stress in the rostral ventrolateral medulla: 2012 Academic Conference Award from the Japanese Society of Hypertension. Hypertens Res. 2013; 36: 845-51.
Lim SS, Kakoly NS, Tan JWJ, Fitzgerald G, Bahri Khomami M, Joham AE, Cooray SD, Misso ML, Norman RJ, Harrison CL, Ranasinha S, Teede HJ, Moran LJ. Metabolic syndrome in polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression. Obes Rev. 2019; 20: 339-352.
Ciccarelli C, Santulli G, Pascale V, Trimarco B, Iaccarino G. Adrenergic receptors and metabolism: role in development of cardiovascular disease. Front Physiol. 2013; 4: 265-270.
Lara HE, Dorfman M, Venegas M, Luza SM, Luna SL, Mayerhofe A, et al. Changes in sympathetic nerve activity of the mammalian ovary during a normal estrous cycle and in polycystic ovary syndrome: Studies on norepinephrine release. Microsc Res Tech. 2002; 59: 495-502.
Tellechea ML, Muzzio DO, Iglesias Molli AE, Belli SH, Graffigna MN, Levalle OA, Frechtel GD, Cerrone GE. Association between β2-adrenoceptor (ADRB2) haplotypes and insulin resistance in PCOS .Clin Endocrinol (Oxf). 2013; 78: 600-6.
Zangeneh FZ, Abdollahi A, Aminee F, Naghizadeh MM. Locus coeruleus lesions and PCOS: role of the central and peripheral sympathetic nervous system in the ovarian function of rat. Iran J Reprod Med. 2012; 10: 113–120.
Patel K, Coffler MS, Dahan MH, Malcom PJ, Deutsch R, Chang RJ. Relationship of GnRH-stimulated LH release to episodic LH secretion and baseline endocrine-metabolic measures in women with polycystic ovary syndrome. Clinical Endocrinology. 2004; 60: 67–74.
Lobo RA, Granger LR, Paul WL, Goebelsmann U, Mishell DR Jr. Psychological stress and increases in urinary norepinephrine metabolites, platelet serotonin, and adrenal androgens in women with polycystic ovary syndrome. Am J Obstet Gynecol. 1983; 145: 496-503.
Barria A, Leyton V, Ojeda SR, Lara HE. Ovarian steroidal response to gonadotropins and beta-adrenergic stimulation is enhanced in polycystic ovary syndrome: role of sympathetic innervation. Endocrinology 1993; 133: 2696-2703.
Desai V, Prasad NR, Manohar SM, Sachan A. Narasimha SR ,Bitla AR. Oxidative Stress in Non-Obese Women with Polycystic Ovarian Syndrome. J Clin Diagn Res. 2014; 8: CC01-CC03.
Bañuls C, Rovira-Llopis S, Martinez de Marañon A, Veses S, Jover A, Gomez M, Rocha M, Hernandez-Mijares A, Victor VM. Metabolic syndrome enhances endoplasmic reticulum, oxidative stress and leukocyte-endothelium interactions in PCOS. Metabolism. 2017; 71: 153-162.
Victor VM, Rovira-Llopis S, Bañuls C, Diaz-Morales N, Martinez de Marañon A, Rios-Navarro C, Alvarez A, Gomez M1, Rocha M1, Hernández-Mijares A. Insulin Resistance in PCOS Patients Enhances Oxidative Stress and Leukocyte Adhesion: Role of Myeloperoxidase. PLoS One. 2016;11:e0151960.
Lee SH, Zabolotny JM, Huang H, Lee H, Kim Y. Insulin in the nervous system and the mind: Functions in metabolism, memory and mood. Mol Metab. 2016; 5: 589–601.
Air EL, Strowsk,MZ, Benoit SC, Conarello SL, Salituro GM,Guan XM. Small molecule insulin mimetics reduce food intake and body weight and prevent development of obesity. Nat Med 2002b; 8:179-183.
Timper K, Brüning J. Hypothalamic circuits regulating appetite and energy homeostasis: pathways to obesity. Dis Model Mech. 2017; 10: 679–689.
Falkowska A, Gutowska I, Goschorska M, Nowacki P, Chlubek D,Baranowska-Bosiacka I. Energy Metabolism of the Brain, Including the Cooperation between Astrocytes and Neurons, Especially in the Context of Glycogen Metabolism. Int J Mol Sci. 2015; 16: 25959-25981.
Rojas J, Chávez M, Olivar L, Rojas M, Morillo J, Mejías J, Calvo M, Bermúdez V. Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth. International Journal of Reproductive Medicine. 2014; 2014; Article ID 719050, 17 pages.
Bairey Merz CN, Elboudwarej O, Mehta P. The autonomic nervous system and cardiovascular health and disease: a complex balancing act. JACC Heart Fail. 2015; 3: 383-385.
Chen C. Smothers J, Lange A, Nestler JE, Strauss Iii JF, Wickham Iii EP. Sex hormone-binding globulin genetic variation: associations with type 2 diabetes mellitus and polycystic ovary syndrome. Minerva Endocrinol. 2010; 35: 271-80.
Nitsche K, Ehrmann DA. Obstructive sleep apnea and metabolic dysfunction in polycystic ovary syndrome. Best Pract Res Clin Endocrinol Metab 2010; 24: 717-30.
Zangeneh FZ. Polycystic ovary syndrome and sympathoexcitation: management of stress and lifestyle. Journal of Biology and Today's world. 2017; 6:146-154.
Mancia G, Bousquet P, Elghozi JL, Esler M, Grassi G, Julius S, Reid J, Van Zwieten PA. The sympathetic nervous system and the metabolic syndrome. J Hypertens. 2007; 25: 909-20.
Mahalingaiah S, Diamanti-Kandarakis E. Targets to treat metabolic syndrome in polycystic ovary syndrome. Expert Opin Ther Targets. 2015; 19: 1561–1574.
Lim SS, Kakoly NS, Tan JWJ, Fitzgerald G, Bahri Khomami M, Joham AE, Cooray SD, Misso ML, Norman RJ, Harrison CL, Ranasinha S, Teede HJ, Moran LJ. Metabolic syndrome in polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression. Obes Rev. 2019; 20: 339-352.
Zhu S, Zhang B, Jiang X, Li Z, Zhao S, Cui L, Chen ZJ. Metabolic disturbances in non-obese women with polycystic ovary syndrome: a systematic review and meta-analysis. Fertil Steril. 2019; 111: 168-177.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Authors
This work is licensed under a Creative Commons Attribution 4.0 International License.
The journal is licensed under a Attribution 4.0 International (CC BY 4.0).
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution - You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions - You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
